Related Experiment Video
Updated: Feb 24, 2026

Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers
Published on: October 28, 2015
Regulating Near-Infrared Photodynamic Properties of Semiconducting Polymer Nanotheranostics for Optimized Cancer
Houjuan Zhu1, Yuan Fang2, Qingqing Miao1
1School of Chemical and Biomedical Engineering, Nanyang Technological University , Singapore 637457, Singapore.
Abstract:
Development of optical nanotheranostics for the capability of photodynamic therapy (PDT) provides opportunities for advanced cancer therapy. However, most nanotheranostic systems fail to regulate their generation levels of reactive oxygen species (ROS) according to the disease microenvironment, which can potentially limit their therapeutic selectivity and increase the risk of damage to normal tissues. We herein report the development of hybrid semiconducting polymer nanoparticles (SPNs) with self-regulated near-infrared (NIR) photodynamic properties for optimized cancer therapy. The SPNs comprise a binary component nanostructure: a NIR-absorbing semiconducting polymer acts as the NIR fluorescent PDT agent, while nanoceria serves as the smart intraparticle regular to decrease and increase ROS generation at physiologically neutral and pathologically acidic environments, respectively. As compared with nondoped SPNs, the NIR fluorescence imaging ability of nanoceria-doped SPNs is similar due to the optically inactive nature of nanoceria; however, the self-regulated photodynamic properties of nanoceria-doped SPN not only result in dramatically reduced nonspecific damage to normal tissue under NIR laser irradiation but also lead to significantly enhanced photodynamic efficacy for cancer therapy in a murine mouse model. This study thus provides a simple yet effective hybrid approach to modulate the phototherapeutic performance of organic photosensitizers.
Insights
Researchers developed hybrid semiconducting polymer nanoparticles (SPNs) for cancer therapy. These SPNs self-regulate reactive oxygen species (ROS) generation, enhancing photodynamic therapy (PDT) efficacy while minimizing damage to healthy tissues.
Area of Science:
- Biomedical Engineering
- Materials Science
- Nanotechnology
Background:
- Optical nanotheranostics offer advanced cancer therapy via photodynamic therapy (PDT).
- Current nanotheranostic systems lack microenvironment-specific regulation of reactive oxygen species (ROS) generation, limiting therapeutic selectivity and increasing off-target tissue damage.
- Developing smart nanocarriers is crucial for precise cancer treatment.
Purpose of the Study:
- To develop hybrid semiconducting polymer nanoparticles (SPNs) with self-regulated near-infrared (NIR) photodynamic properties for enhanced cancer therapy.
- To investigate the role of nanoceria as an intraparticle regulator for ROS generation in response to microenvironmental pH changes.
- To evaluate the therapeutic efficacy and safety of these novel nanotheranostics in a preclinical cancer model.
Main Methods:
- Fabrication of hybrid SPNs incorporating a NIR-absorbing semiconducting polymer and nanoceria.
- Characterization of SPN structure, NIR fluorescence, and ROS generation under varying pH conditions.
- In vitro and in vivo evaluation of SPN photodynamic efficacy, biodistribution, and tissue damage in a murine cancer model.
Main Results:
- The hybrid SPNs exhibited stable NIR fluorescence imaging capabilities.
- Nanoceria doping enabled pH-dependent, self-regulated ROS generation, decreasing ROS at neutral pH and increasing it at acidic pH.
- Nanoceria-doped SPNs demonstrated reduced nonspecific damage to normal tissues and significantly enhanced photodynamic therapeutic efficacy in vivo compared to nondoped SPNs.
Conclusions:
- Hybrid SPNs with self-regulated photodynamic properties offer a promising strategy for optimizing cancer therapy.
- The integration of nanoceria provides a smart regulatory mechanism for ROS generation, improving therapeutic selectivity and safety.
- This approach represents a significant advancement in the design of intelligent nanotheranostics for improved cancer treatment outcomes.
More Related Videos
09:23Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods
Published on: October 10, 2025
06:42Plasmonic Photothermal Cancer Therapy: Nanoparticle-embedded Tumor-tissue-mimicking Phantoms for Visualizing Photothermal Temperature Distribution
Published on: May 9, 2025